These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24532042)

  • 21. Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Jian C; Xiao J; Gong L; Skipwith CG; Jin SY; Kwaan HC; Zheng XL
    Blood; 2012 Apr; 119(16):3836-43. PubMed ID: 22289888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombotic thrombocytopenic purpura in IgG4-related disease with severe deficiency of ADAMTS-13 activity and IgG4 autoantibody against ADAMTS-13.
    Saeki T; Ito T; Youkou A; Ishiguro H; Sato N; Yamazaki H; Koike T; Kourakata H; Ferrari S; Scheiflinger F; Narita I
    Arthritis Care Res (Hoboken); 2011 Aug; 63(8):1209-12. PubMed ID: 21523922
    [No Abstract]   [Full Text] [Related]  

  • 23. Evolution of ADAMTS13 antibodies in a fatal case of thrombotic thrombocytopenic purpura.
    Dong L; Chandrasekaran V; Zhou W; Tsai HM
    Am J Hematol; 2008 Oct; 83(10):815-7. PubMed ID: 18661493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.
    Li D; Xiao J; Paessler M; Zheng XL
    Thromb Haemost; 2011 Nov; 106(5):947-58. PubMed ID: 21901237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor.
    Kosugi N; Tsurutani Y; Isonishi A; Hori Y; Matsumoto M; Fujimura Y
    Intern Med; 2010; 49(7):689-93. PubMed ID: 20371960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
    Mazepa MA; Raval JS; Moll S; Ma A; Park YA
    Br J Haematol; 2014 Mar; 164(6):900-2. PubMed ID: 24345005
    [No Abstract]   [Full Text] [Related]  

  • 27. Characterisation of autoantibody repertoire is needed in thrombotic thrombocytopenia purpura.
    Scally B; Loan J
    Thromb Res; 2013 Sep; 132(3):e165. PubMed ID: 23768450
    [No Abstract]   [Full Text] [Related]  

  • 28. Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.
    Franchini M; Mannucci PM
    Blood Transfus; 2008 Jul; 6(3):127-35. PubMed ID: 18705236
    [No Abstract]   [Full Text] [Related]  

  • 29. Nonneutralizing IgM and IgG antibodies to von Willebrand factor-cleaving protease (ADAMTS-13) in a patient with thrombotic thrombocytopenic purpura.
    Scheiflinger F; Knöbl P; Trattner B; Plaimauer B; Mohr G; Dockal M; Dorner F; Rieger M
    Blood; 2003 Nov; 102(9):3241-3. PubMed ID: 12855569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving on nature: redesigning ADAMTS13.
    Kremer Hovinga JA; Voorberg J
    Blood; 2012 Apr; 119(16):3654-5. PubMed ID: 22517874
    [No Abstract]   [Full Text] [Related]  

  • 31. ADAMTS13 antibody depletion by bortezomib in thrombotic thrombocytopenic purpura.
    Shortt J; Oh DH; Opat SS
    N Engl J Med; 2013 Jan; 368(1):90-2. PubMed ID: 23281998
    [No Abstract]   [Full Text] [Related]  

  • 32. Familial acquired thrombotic thrombocytopenic purpura: ADAMTS13 inhibitory autoantibodies in identical twins.
    Studt JD; Kremer Hovinga JA; Radonic R; Gasparovic V; Ivanovic D; Merkler M; Wirthmueller U; Dahinden C; Furlan M; Lämmle B
    Blood; 2004 Jun; 103(11):4195-7. PubMed ID: 14982879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ADAMTS13 autoantibodies cloned from patients with acquired thrombotic thrombocytopenic purpura: 1. Structural and functional characterization in vitro.
    Ostertag EM; Kacir S; Thiboutot M; Gulendran G; Zheng XL; Cines DB; Siegel DL
    Transfusion; 2016 Jul; 56(7):1763-74. PubMed ID: 27040144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Pos W; Luken BM; Kremer Hovinga JA; Turenhout EA; Scheiflinger F; Dong JF; Fijnheer R; Voorberg J
    J Thromb Haemost; 2009 Mar; 7(3):421-8. PubMed ID: 19054323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acquired TTP: ADAMTS13 meets the immune system.
    Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
    Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
    Rieger M; Mannucci PM; Kremer Hovinga JA; Herzog A; Gerstenbauer G; Konetschny C; Zimmermann K; Scharrer I; Peyvandi F; Galbusera M; Remuzzi G; Böhm M; Plaimauer B; Lämmle B; Scheiflinger F
    Blood; 2005 Aug; 106(4):1262-7. PubMed ID: 15890682
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thrombotic thrombocytopenic purpura due to anti-ADAMTS13 antibodies in multiple myeloma.
    Yao H; Monge M; Renou M; Lecaque C; Jauréguy M; Presne C; Makdassi R; Choukroun G
    Clin Nephrol; 2014 Mar; 81(3):210-5. PubMed ID: 23073062
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies.
    Bresin E; Gastoldi S; Daina E; Belotti D; Pogliani E; Perseghin P; Scalzulli PR; Paolini R; Marcenò R; Remuzzi G; Galbusera M
    Thromb Haemost; 2009 Feb; 101(2):233-8. PubMed ID: 19190804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients.
    Schelpe AS; Roose E; Joly BS; Pareyn I; Mancini I; Biganzoli M; Deckmyn H; Voorberg J; Fijnheer R; Peyvandi F; De Meyer SF; Coppo P; Veyradier A; Vanhoorelbeke K
    Haematologica; 2019 Jun; 104(6):1268-1276. PubMed ID: 30523052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.